Presentation is loading. Please wait.

Presentation is loading. Please wait.

A History of CPAP for Infants

Similar presentations


Presentation on theme: "A History of CPAP for Infants"— Presentation transcript:

1 A History of CPAP for Infants
Alan H. Jobe, MD, PhD Cincinnati Children’s Hospital University of Cincinnati Cincinnati, Ohio

2 Neonatal Bioethics: The Moral Challenges of medical Intervention
The era of innovation and individualism Mechanical Ventilation CPAP Total Parental Nutrition Regionalization Era of exposed ignorance – The End of Medical Progress – after 1992 Lantos and Meadow, Neonatal Bioethics, 2006

3 First Reference to CPAP in Pub Med: Revival of an Old Battle: Intermittent vs. Continuous Positive-Pressure Breathing Continuous Pressure Breathing – effective in WWII for high altitude pilots, but increases work of breathing and decreases cardiac output. Advantages of CPB over IPB Improved oxygenation at lower FiO2 Disadvantages of CPP over IPB Need to measure CO “Indicated only in cases where alveolar pressure is not transmitted to the intra plural spaces” Alveolar rupture and Pneumothorax Editorial in NEJM – December, 1970, Claude Lenfant VIENNA-09

4 VIENNA-09 8 Patients with “Severe Acute Respiratory Failure” Ventilated using a PEEP of 13 cmH2O Kunar, et al., NEJM, 1970

5 Responses of Switching 8 Patients from PEEP=13 cmH2O to No PEEP
Kunar, et al., NEJM, 1970 VIENNA-09

6 Status of Hyaline Membrane Disease – Late 1960’s
HMD was leading cause of death for preterms (27%-43% survival with assisted ventilation worldwide) Ventilation resulted in Bronchopulmonary Dysplasia (oxygen toxicity) – Northway (1967) * No antenatal testing for lung maturation – (Gluck, 1971) * No antenatal corticosteroids (Liggins – 1972) * No surfactant treatments (Fujuwara – 1980) * No effective therapy other than supplemental oxygen VIENNA-09

7 Information about HMD in Late 1960’s
Atelectasis in HMD interfered with oxygenation Normal lungs contained surfactant (Clements – 1957) HMD lungs were surfactant deficient (Avery and Mead – 1959) Intubation of HMD infants abolished grunting and decreased oxygenation (Harrison, et al., 1968) Ventilation with a long Ti increased oxygenation (Smith, et al., 1969) VIENNA-09

8 Pediatr, 1968 VIENNA-09

9 5 Infants tested for change in Oxygenation with Intubation - on 90-95% Oxygen
PaO2 Values Before Intubated Intubated Extubated 91 ± 91 61 ± 58* 93 ± 92 *1.8±0.4 kg; Pco2=51±7 p<0.001 Harrison, et al., Pediatr, 1968

10 Nasal Piece and Fleish Tube used for PFT Measurements
Fig. 1. Fleisch 00 Pnumotachograph, T-junction, and nasal piece. Harrison, et al., Pediatr, 1968

11 Abstract for SPR/APS Meeting 1970
VIENNA-09

12 VIENNA-09

13 20 - Required 100% or had Apnea 1 - Ventilated from Birth
20 Infants Treated with CPAP over 16 Months 51 Infants with IRDS UA lines, O2 for Pao2 of mmHg 20 - Required 100% or had Apnea 5 - Apnic at Birth 1 - Ventilated from Birth 25 - Increased O2 Only All Survived Bag & Mask Ventilation Ventilated 1 Survived CPAP All Died 16 Survived Data from Gregory NEJM, 1971 VIENNA-09

14 CPAP Device for use with Endotracheal Tube
Gregory, et al., NEJM, 1971 VIENNA-09

15 CPAP Device for use with Endotracheal Tube
Gregory, et al., NEJM, 1971 VIENNA-09

16 Head Box for CPAP without Endotracheal Tube
VIENNA-09 Gregory, et al., NEJM, 1971

17 CPAP Provided by G. Gregory
This is a trash bag with gas inflow. It was closed loosely about the neck and pressure could be maintained easily and constantly. This was about the 5th or 6th patient we treated. Provided by G. Gregory

18 • 20 infants, BW 930 to 3,830g • Severe HMD (PaO2 <50 mmHg in % O2 or apneic) • Range of highest CPAP: 6-12 mmHg • PES by only 20% of applied CPAP • Duration of CPAP: 2-29 d • 16 of 20 survived • No CLD (chronic lung disease) Results: Provided by A. Wilkinson

19 Effects of CPAP on Lung Volume
CPAP (mmHg) CPAP (mmHg) FRC (ml) Provided by A. Wilkinson

20 From Gregory, et al., NEJM - 1971
“We did not consider an elevation in Paco2 to be an indicator for mechanical ventilation as long as pH was greater than 7.20.” Footnote for physiologic data – Order NAPS document from National Auxiliary Publications Service – (the physiologic data has been lost) .20 VIENNA-09

21 CPAP Worked – and Rapid Innovation Occurred
Continuous negative Pressure (Chernick and Vidyasargar – 1972) Fanaroff, et al. (1973) Pressurized bag over head (Barrie, 1973) Mask that covers the mouth and nose (Harris, 1972) Nasal CPAP (Kattwinkel, et al., 1973) Ventilation + CPAP = PEEP (Cumarassamy, et al., 1973) VIENNA-09

22 A Bag and Y-Connector for CPAP
VIENNA-09 Barrie, The Lancet, 1973

23 Caliumi-Pellegrini, et al., Arch Dis Child, 1974
VIENNA-09

24 Schematic representation of the system used for applying continuous positive airway pressure (adapted from Gregory, et al.) VIENNA-09 Cumarasamy, et al., Pediatrics, 1973

25 Artificial Ventilation in HMD: the use of PEEP and CPAP
Treatment Outcomes with PEEP + CPAP by Year Years 1969 1970 1971 Number of Patients % Ventilated % Survival Overall 36 36% 53% 38 58% 44% 46 78% 74% Ventilated 23% 70% Cumarasamy, Nussli, Vischer, Dangel & Duc, Pediatrics, 1973 VIENNA-09

26 Effect of CPAP (PEEP) on Intubated and Ventilated Infants with RDS
deLemos, McLaughlin, Robison, Schulz, Kirby, Anesthesia & Analgesia, 1973 VIENNA-09

27 Nasal Prongs for CPAP Kattwinkel, Fleming, Cha, and Fanaroff, Pediatrics, 1973

28 Nasal CPAP (2-5 cmH2O) for Infants with Apnea.
BW average = 1kg, age of study – 14 days Kattwinkel, et al., J. Pediatr, 1975

29 Follow-up Measurements to Evaluate Mechanical Ventilation, Oxygen, and CPAP for Lung Damage
Ventilated CPAP Number Birth Weight (kg) Gestational Age (weeks) Duration of Supplemental O2 > 60% (hr) Duration of IPPV (hr) Duration of CPAP (hr) 11 1.6±0.2 31.7±0.6 38±10 56±10 - 8 2.2±0.2 34.1±1.1 11±3 48±9 Stocks and Godfrey, Pediatrics, 1976

30 Airway Conductance Measured at Term and at 4-11 Months Post-Delivery
CPAP Stocks & Godfrey, Pediatrics, 1976

31 Meta-Analysis of CPAP vs. No CPAP for Infants with RDS
Outcome N- Studies N-Patients Risk Ratio 95% CI Require Mech Vent Air Leaks BPD Death 4 2 145 165 100 0.66 2.62 0.87 Bancalari & Sinclair, in Effective Care of the Newborn Infant: Sinclair and Bracken, 1992

32 1980’s through early 2000 Ventilation replaced CPAP as primary therapy for RDS Antenatal steroids and surfactant decreased severity of RDS BPD was frequent in VLBW infants

33 CPAP was used frequently for -
Apnea of prematurity Post extubation after mechanical ventilation RDS in some locations (Columbia, Univ. Scandinavia)

34 CPAP-VENT

35 Effect of a change in delivery room management for infants <1000g - allowing spontaneous breathing with FRC recruitment and CPAP CPAP-VENT

36 The Danish Approach to the Initiation of Ventilation and Surfactant
CPAP-VENT

37 The Coin Trial Ventilation CPAP P N BW % Intubated by 5d
% Surfactant by 5d 303 952 100% 77% 307 964 46% 38% * Morley, et al., NEJM, 2008

38 The Coin Trial - 36 Week Outcome
Ventilation CPAP P Pneumothorax Median Vent days Death BPD - 28d BPD - 36wk O2 Concentration at 36wk >30% 3% 4 5.9% 63% 31% 8.8% 9% 3 6.5% 51% 29% 9.4% <0.01 NS 0.01 Morley, et al., NEJM, 2008

39 Neonatal Bioethics: The Moral Challenges of medical Intervention
The era of innovation and individualism Mechanical Ventilation CPAP Total Parental Nutrition Regionalization Era of exposed ignorance – The End of Medical Progress Lantos and Meadow, Neonatal Bioethics, 2006

40 CPAP in 2009 – A New Enthusiasm
Again frequently used as an initial therapy for RDS ± surfactant Early (delivery room) use popular and under study New types of CPAP Nasal CPAP + Ventilatory assist (synchronized, NAVA) Multiple CPAP devices (NeopuF) High flow nasal cannula Variable pressure CPAP

41 My thanks to George Gregory for his help with this brief history of CPAP


Download ppt "A History of CPAP for Infants"

Similar presentations


Ads by Google